/
Incorporated in 2022, we are a holding company for existing and future planned operating companies centered around pharmaceuticals and healthcare services. We seek to be a micro health ecosystem, with a portfolio of companies consisting of a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services.
The business is unprofitable at the operating level (-401.70% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 28.7%, still solid. Margins contracted 367.8pp, which offsets some of the top-line progress.
ROIC dropped from -30.56% to -264.16%, capital efficiency is deteriorating. Operating margin contracted 367.8pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
$14M
▲ +28.7% YoY
Net Income (TTM)
-$77M
▼ -1377.1% YoY
Op. Margin
-487.50%
▼ -367.8pp YoY
ROIC
-193.15%
▼ -233.6pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$13M
▼ -786.1% YoY
Net Debt
$29M
Cash & Equiv.
$52K
Continue Research